Reichl D, Myant N B, Brown M S, Goldstein J L
J Clin Invest. 1978 Jan;61(1):64-71. doi: 10.1172/JCI108926.
We have compared the ability of human serum and peripheral lymph to suppress the activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase), to activate cholesteryl ester synthesis, and to compete with 125I-labeled low density lipoprotein (LDL) for binding to LDL receptors in cultured human fibroblasts. Whole lymph was active in all three tests and the activity per unit volume in lymph was approximately equal to 1/10th that in serum. All three biologic activities in lymph were confined to the d less than 1.063 g/ml fraction. Whole lymph had no significant effect on HMG-CoA reductase activity in fibroblasts from a patient with homozygous familial hypercholesterolemia, whose cells lack LDL receptors. The LDL-like biologic activity per unit mass of immunologically active apoprotein B was approximately the same in lymph as in serum. The current data indicate that functionally active LDL is present in lymph and that the concentration of this lipoprotein is approximately equal to 1/10th that in serum.
我们比较了人血清和外周淋巴抑制3-羟基-3-甲基戊二酰辅酶A还原酶(HMG-CoA还原酶)活性、激活胆固醇酯合成以及与125I标记的低密度脂蛋白(LDL)竞争结合培养的人成纤维细胞中LDL受体的能力。全淋巴在所有这三项试验中均有活性,且每单位体积淋巴中的活性约为血清中活性的1/10。淋巴中的所有这三种生物学活性均局限于密度小于1.063 g/ml的部分。全淋巴对纯合子家族性高胆固醇血症患者的成纤维细胞中的HMG-CoA还原酶活性没有显著影响,该患者的细胞缺乏LDL受体。每单位质量具有免疫活性的载脂蛋白B的LDL样生物学活性在淋巴中与血清中大致相同。目前的数据表明,淋巴中存在具有功能活性的LDL,且这种脂蛋白的浓度约为血清中浓度的1/10。